Keyphrases
Urinary Tract Infection
100%
FimH
100%
Orally Active
100%
Chronic Urinary Tract Infection
100%
Uropathogenic Escherichia Coli
75%
Recurrent Urinary Tract Infections (rUTIs)
50%
Small Molecular
50%
Treatment Options
25%
Effective Treatment
25%
Oral Administration
25%
Lectin
25%
Pili
25%
Therapeutic Efficacy
25%
Type 1 pili
25%
Adhesin
25%
Outer Membrane
25%
Mechanism of Action
25%
Trimethoprim-sulfamethoxazole (TMP-SMX)
25%
Bladder Urothelium
25%
Medical Problems
25%
Unique Mechanism
25%
Intracellular Bacterial Communities
25%
Oral Bioavailability
25%
Antibiotic Resistant
25%
Resistance Development
25%
Bacterial Colonization
25%
In Vivo murine Model
25%
Mannoside
25%
Prophylactic Antibiotics
25%
Standard-of-care Therapy
25%
Fast-acting
25%
Escherichia Coli Bacteria
25%
Drug Penetration
25%
Medicine and Dentistry
Urinary Tract Infection
100%
Uropathogenic Escherichia Coli
50%
Pilus
33%
Infection
16%
Combination Therapy
16%
Oral Drug Administration
16%
Bioavailability
16%
Bacterial Colonization
16%
Lectin
16%
Escherichia coli
16%
Trimethoprim/Sulfamethoxazole
16%
Adhesin
16%
Outer Membrane
16%
Mannoside
16%
Bladder Epithelium
16%
Drug Penetration
16%
Antibiotics
16%
Diseases
16%
Pharmacology, Toxicology and Pharmaceutical Science
Urinary Tract Infection
100%
Uropathogenic Escherichia Coli
50%
Infection
16%
Combination Therapy
16%
Antibiotics
16%
Escherichia coli
16%
Cotrimoxazole
16%
Adhesin
16%
Bioavailability
16%
Lectin
16%
Mannoside
16%
Diseases
16%
Immunology and Microbiology
Urinary Tract
100%
Uropathogenic Escherichia Coli
50%
Pilus
33%
Molecular Weight
33%
Escherichia coli
16%
Lectin
16%
Outer Membrane
16%
Bladder Epithelium
16%
Bacterial Colonization
16%
Drug Penetration
16%